NewGenIvf Group (NASDAQ:NIVF) & Elevance Health (NYSE:ELV) Critical Contrast

Elevance Health (NYSE:ELV) and NewGenIvf Group (NASDAQ:NIVF) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, earnings, dividends, analyst recommendations and risk.

Analyst Ratings

This is a summary of current recommendations and price targets for Elevance Health and NewGenIvf Group, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Elevance Health	1	10	12	0	2.48
NewGenIvf Group	1	0	0	0	1.00

Elevance Health presently has a consensus price target of $397.33, suggesting a potential upside of 25.40%. Given Elevance Health’s stronger consensus rating and higher probable upside, research analysts clearly believe Elevance Health is more favorable than NewGenIvf Group.

Valuation and Earnings

This table compares Elevance Health and NewGenIvf Group”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Elevance Health	$194.82 billion	0.36	$5.98 billion	$24.46	12.95
NewGenIvf Group	$5.43 million	0.18	-$520,000.00	N/A	N/A

Elevance Health has higher revenue and earnings than NewGenIvf Group.

Insider & Institutional Ownership

89.2% of Elevance Health shares are held by institutional investors. Comparatively, 66.2% of NewGenIvf Group shares are held by institutional investors. 0.3% of Elevance Health shares are held by company insiders. Comparatively, 31.8% of NewGenIvf Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Risk & Volatility

Elevance Health has a beta of 0.6, indicating that its share price is 40% less volatile than the S&P 500. Comparatively, NewGenIvf Group has a beta of -0.12, indicating that its share price is 112% less volatile than the S&P 500.

Profitability

This table compares Elevance Health and NewGenIvf Group’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Elevance Health	2.84%	16.17%	5.78%
NewGenIvf Group	N/A	N/A	N/A

Summary

Elevance Health beats NewGenIvf Group on 11 of the 12 factors compared between the two stocks.

About Elevance Health

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.

About NewGenIvf Group

NewGenIVF Group Ltd. operates as an assisted reproductive services provider. It focuses on providing fertility treatments to fulfil the dreams of building families. The firm offers in-vitro fertilization treatment service, comprising traditional IVF and egg donation, and surrogacy and ancillary caring services. The company was founded by Siu Wing Fung and Fong Hei Yue on January 16, 2019 and is headquartered in Bangkok, Thailand.